Actively Recruiting
Impact of COVID19 Outbreak in Cardiac Patients Admitted in Intensive Care Unit : the CCU-COVID19 Study
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2024-10-15
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
A
Action, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to understand how the COVID-19 outbreak affected cardiac patients admitted to the Intensive Care Unit (ICU) at Pitie-Salpetriere Hospital in Paris, France. It compares patients who tested positive for COVID-19 with those who did not have the infection, focusing on those with acute coronary syndrome and heart failure. The study is observational, tracking patient outcomes during and after their ICU stay. The study involves collecting diagnostic and prognostic data from cardiac patients admitted to the ICU during the COVID-19 outbreak. Patients are grouped based on their COVID-19 status, confirmed by RT-PCR and CT scans. Researchers assess immune status by checking for SARS-CoV-2 specific antibodies. No treatment is assigned as this is an observational registry. Participants will be followed from admission through one year afterward to monitor the incidence of major cardiovascular events and urgent rehospitalizations. Data on clinical characteristics and outcomes will be collected during their ICU stay and follow-up. The study ensures patient consent and tracks health events to better understand COVID-19's impact on cardiac care.
CONDITIONS
Brief Title
Impact of COVID19 Outbreak in Cardiac Acute Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years and older
- Admitted in the Cardiac Intensive Care Unit from March 20th 2020
- Patient informed and having expressed his non-opposition to participate in the research
You will not qualify if you...
- Minor patient
- Patient who expressed opposition to participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From admission in the Cardiac Intensive Care Unit
Participants undergo diagnostic and prognostic evaluation including assessment of cardiac condition and immune status related to COVID-19.
1 to 2 visits depending on antibody levels
Duration - Up to 1 year follow-up
Participants are monitored for incidence of recurrent major cardiovascular events and urgent rehospitalization over one year following admission.
Periodic visits for follow-up assessments
Trial Site Locations
Total: 1 location
1
Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP
Paris, France, 75013
Actively Recruiting
Research Team
J
Johanne SILVAIN, MD PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here